earticle

논문검색

세포치료 및 조직공학

The Effects of Exendin-4 on the Viability and Insulin Secretion of Microencapsulated Pancreatic Islets

초록

영어

The immunoisolation not only allows for successful transplantation of cells in the absence of immunosuppression but also for transplantation of cells from nonhuman origin. Microcapsules have been one of the most intensively studied extravascular devices because of the spherical shape and mechanical stability. However, it is reported that there may be some limitations for the microcapsules due to oxygen shortage and reduced diffusion capacity. Thus, this study was performed to evaluate the effects of exendin-4 on the viability and insulin secretion of microencapsulated islets. Pancreatic islets were isolated from male Sprague–Dawley rats and the exendin-4 was transduced into the islets. Microcapsules were prepared using an electrostatic bead generator. Microencapsulation of the untrasnduced islets was considered as control and the exendin-transduced one was regarded as test group. The mechanical stability of the microcapsules was determined using an osmotic pressure test and a rotational stress test. The viability and the insulin secretion stimulated by glucose were measured. After islet transplantation of the encapsulated islets, animals’ body weight and blood glucose levels of encapsulated islet recipients were monitored daily.It was shown that the exendin-4 transduced islets showed higher viability when compared with the control. Both groups were able to produce the insulin from the glucose challenge and the absolute amount of secreted insulin was higher in the test group. It may be suggested that the transduction of exendin-4 may be considered for the microencapsulation procedure to enhance the viability and the insulin secretion from the islets.

저자정보

  • Jun-Beom PARK Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 151-742, Korea.
  • Jee-Heon JEONG Department of Manufacturing Pharmacy, College of Pharmacy, Seoul National University, Seoul, 151-742, Korea.
  • Yoon Suk JUNG Department of Manufacturing Pharmacy, College of Pharmacy, Seoul National University, Seoul, 151-742, Korea.
  • Sim myung YOOK Department of Manufacturing Pharmacy, College of Pharmacy, Seoul National University, Seoul, 151-742, Korea.
  • Khue CAO DUY Department of Manufacturing Pharmacy, College of Pharmacy, Seoul National University, Seoul, 151-742, Korea.
  • Sung Woo HONG Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 151-742, Korea.
  • Bok Hyeon IM Department of Manufacturing Pharmacy, College of Pharmacy, Seoul National University, Seoul, 151-742, Korea.
  • Jin Won SEO Department of Manufacturing Pharmacy, College of Pharmacy, Seoul National University, Seoul, 151-742, Korea.
  • Dong Yun LEE Department of Bioengineering, College of Engineering, Hanyang University, Seoul, 133-791, Korea.
  • Youngro BYUN Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 151-742, Korea.

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

      0개의 논문이 장바구니에 담겼습니다.